87 related articles for article (PubMed ID: 19615205)
1. [Clinical significance of serum levels of endostatin in patients with clear cell renal cell carcinoma].
Guan KP; Xiao ZD; Wang D; Shi HZ; Guan YY; Lu L; Han SJ; Li CL
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):737-9. PubMed ID: 19615205
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
Schips L; Dalpiaz O; Lipsky K; Langner C; Rehak P; Puerstner P; Pummer K; Zigeuner R
Eur Urol; 2007 Jan; 51(1):168-73; discussion 174. PubMed ID: 16844285
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of pretreatment serum level of endostatin to posttreatment distant metastasis in patients with advanced nasopharyngeal carcinoma].
Zhao ZJ; Mo HY; Zhang CQ; Qi B; Li J; Hong MH; Mai HQ
Ai Zheng; 2007 Nov; 26(11):1243-7. PubMed ID: 17991326
[TBL] [Abstract][Full Text] [Related]
4. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma.
Feldman AL; Alexander HR; Yang JC; Linehan WM; Eyler RA; Miller MS; Steinberg SM; Libutti SK
Cancer; 2002 Oct; 95(8):1637-43. PubMed ID: 12365010
[TBL] [Abstract][Full Text] [Related]
5. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.
Feldman AL; Tamarkin L; Paciotti GF; Simpson BW; Linehan WM; Yang JC; Fogler WE; Turner EM; Alexander HR; Libutti SK
Clin Cancer Res; 2000 Dec; 6(12):4628-34. PubMed ID: 11156212
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of interleukin-18 and nitrite+nitrate in renal cell carcinoma patients with different tumor stage and grade.
Sözen S; Coskun U; Sancak B; Bukan N; Günel N; Tunc L; Bozkirli I
Neoplasma; 2004; 51(1):25-9. PubMed ID: 15004655
[TBL] [Abstract][Full Text] [Related]
7. Serum endostatin levels in patients with lung carcinoma.
Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E
Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
[TBL] [Abstract][Full Text] [Related]
8. Serum endostatin levels in patients with epithelial ovarian cancer.
Hata K; Dhar DK; Kanasaki H; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Nagasue N; Miyazaki K
Anticancer Res; 2003; 23(2C):1907-12. PubMed ID: 12820477
[TBL] [Abstract][Full Text] [Related]
9. [The value of serum endostatin level in early diagnosis of lung cancer].
Xu AH; Yin YW; Chen FH
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(27):1916-8. PubMed ID: 17064531
[TBL] [Abstract][Full Text] [Related]
10. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
11. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma.
Horiguchi A; Ito K; Sumitomo M; Kimura F; Asano T; Hayakawa M
Jpn J Clin Oncol; 2008 Feb; 38(2):106-11. PubMed ID: 18245516
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma.
Bono P; Teerenhovi L; Joensuu H
Cancer; 2003 Jun; 97(11):2767-75. PubMed ID: 12767089
[TBL] [Abstract][Full Text] [Related]
13. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
14. Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma.
Paju A; Jacobsen J; Rasmuson T; Stenman UH; Ljungberg B
J Urol; 2001 Mar; 165(3):959-62. PubMed ID: 11176522
[TBL] [Abstract][Full Text] [Related]
15. High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment.
Urbańska-Ryś H; Robak T
Mediators Inflamm; 2003 Aug; 12(4):229-35. PubMed ID: 14514474
[TBL] [Abstract][Full Text] [Related]
16. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
17. Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW
BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of collagen XVIII is associated with poor outcome and elevated levels of circulating serum endostatin in non-small cell lung cancer.
Iizasa T; Chang H; Suzuki M; Otsuji M; Yokoi S; Chiyo M; Motohashi S; Yasufuku K; Sekine Y; Iyoda A; Shibuya K; Hiroshima K; Fujisawa T
Clin Cancer Res; 2004 Aug; 10(16):5361-6. PubMed ID: 15328173
[TBL] [Abstract][Full Text] [Related]
19. Correlations between serum levels of vascular endothelial growth factor and endostatin with clinical pathological characteristics of patients with gastrointestinal cancers.
Li M; Liu F; Sun P; Gao Y; Chen H; Liu H; Wang M; Chen J; Zhao Y
Hepatogastroenterology; 2012 Sep; 59(118):1865-8. PubMed ID: 22819906
[TBL] [Abstract][Full Text] [Related]
20. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
Kurschat P; Eming S; Nashan D; Krieg T; Mauch C
Br J Dermatol; 2007 Apr; 156(4):653-8. PubMed ID: 17263813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
